» Articles » PMID: 27990344

Applicability of Digital PCR to the Investigation of Pediatric-onset Genetic Disorders

Overview
Date 2016 Dec 20
PMID 27990344
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Early-onset rare diseases have a strong impact on child healthcare even though the incidence of each of these diseases is relatively low. In order to better manage the care of these children, it is imperative to quickly diagnose the molecular bases for these disorders as well as to develop technologies with prognostic potential. Digital PCR (dPCR) is well suited for this role by providing an absolute quantification of the target DNA within a sample. This review illustrates how dPCR can be used to identify genes associated with pediatric-onset disorders, to identify copy number status of important disease-causing genes and variants and to quantify modifier genes. It is also a powerful technology to track changes in genomic biomarkers with disease progression. Based on its capability to accurately and reliably detect genomic alterations with high sensitivity and a large dynamic detection range, dPCR has the potential to become the tool of choice for the verification of pediatric disease-associated mutations identified by next generation sequencing, copy number determination and noninvasive prenatal screening.

Citing Articles

Genomic Copy Number Analysis Using Droplet Digital PCR: A Simple Method with EvaGreen Single-Color Fluorescent Design.

Tamura T, Imaizumi T, Shimojima Yamamoto K, Yamamoto T Methods Mol Biol. 2024; 2794:293-304.

PMID: 38630238 DOI: 10.1007/978-1-0716-3810-1_24.


Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond.

Parkins M, Lee B, Acosta N, Bautista M, Hubert C, Hrudey S Clin Microbiol Rev. 2023; 37(1):e0010322.

PMID: 38095438 PMC: 10938902. DOI: 10.1128/cmr.00103-22.


Nucleic Acid Based Testing (NABing): A Game Changer Technology for Public Health.

Khera H, Mishra R Mol Biotechnol. 2023; 66(9):2168-2200.

PMID: 37695473 DOI: 10.1007/s12033-023-00870-4.


Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations.

Holland S, Holland L, Smith M, Lee M, Hu J, Lim E Microbiol Spectr. 2023; 11(4):e0525822.

PMID: 37306573 PMC: 10434287. DOI: 10.1128/spectrum.05258-22.


Identification of the Novel Methylated Genes' Signature to Predict Prognosis in INRG High-Risk Neuroblastomas.

Liu Z, Li C J Oncol. 2021; 2021:1615201.

PMID: 34557229 PMC: 8455188. DOI: 10.1155/2021/1615201.


References
1.
Rubben A, Bausch B, Nikkels A . Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR. Mol Cancer. 2006; 5:36. PMC: 1570477. DOI: 10.1186/1476-4598-5-36. View

2.
Barrett A, McDonnell T, Chan K, Chitty L . Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem. 2012; 58(6):1026-32. DOI: 10.1373/clinchem.2011.178939. View

3.
Abou Tayoun A, Mason-Suares H, Frisella A, Bowser M, Duffy E, Mahanta L . Targeted Droplet-Digital PCR as a Tool for Novel Deletion Discovery at the DFNB1 Locus. Hum Mutat. 2015; 37(1):119-26. DOI: 10.1002/humu.22912. View

4.
Stieglitz E, Troup C, Gelston L, Haliburton J, Chow E, Yu K . Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia. Blood. 2014; 125(3):516-24. PMC: 4296011. DOI: 10.1182/blood-2014-09-601690. View

5.
Usher C, Handsaker R, Esko T, Tuke M, Weedon M, Hastie A . Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. Nat Genet. 2015; 47(8):921-5. PMC: 4712930. DOI: 10.1038/ng.3340. View